winda dwi p., dr. nanang munif yasin, m.pharm., apt.; dr
TRANSCRIPT
109
DAFTAR PUSTAKA
Adler, M.W., 1996. Perkembangan Epidemiologi, dalam: Petunjuk Penting AIDS
(ABC of AIDS). Penerbit Buku Kedokteran EGC, Jakarta.
Amin, J., Boyd, M.A., Kumarasamy, N., Moore, C.L., Losso, M.H., Nwizu, C.A.,
dkk., 2015. Raltegravir Non-Inferior to Nucleoside Based Regimens in
SECOND-LINE Therapy with Lopinavir/Ritonavir over 96 Weeks: A
Randomised Open Label Study for the Treatment Of HIV-1 Infection. PLOS
ONE, 10: e0118228.
Anonim, 2007. 'Hasil Monitoring 25 RS Rujukan Pelayanan Kesehatan ODHA
Direktur Jenderal Pelayanan Medik Departemen Kesehatan RI', Yayasan
Mitra INTI. URL: http://www.mitrainti.org/?q=node/340 (diakses tanggal
6/2/2018).
Anonim, 2017. 'DynaMed Plus® The Next-generation , Evidence-based Clinical
Information Resource, Designed to Optimize Time to Answer', EBSCO.
URL: https://www.ebscohost.com/assets-ebrochures/DynaMed-Plus-
eBrochure.pdf?_ga=2.252662543.721294030.1525794474-
884887223.1525204792 (diakses tanggal 1/6/2018).
Arnedo, M., Alonso, E., Eisenberg, N., Ibanez, L., Ferreyra, C., Jaen, A., dkk.,
2012. Monitoring HIV Viral Load in Resource Limited Settings: Still a
Matter of Debate? PLoS ONE, 7: e47391.
Astuti, W. dan Rayasari, F., 2017. Pengalaman Seksual Pasangan Penderita HIV
dalam Mempertahankan Status HIV Negatif di RSPI Prof. Dr. Sulianti
Saroso. Indonesian Journal of Nursing Practices, 1: 32–43.
Bartlett, J. (Editor), 2012. CD4 Cell Count and the Risk of AIDS or Death in HIV-
Infected Adults on Combination Antiretroviral Therapy with a Suppressed
Viral Load: A Longitudinal Cohort Study from COHERE. PLoS Medicine,
9: e1001194.
Barus, T., Anwar, Y., dan Ginting, D., 2017. Evaluasi Efek Samping Obat
Antiretroviral dan Penatalaksanaanya pada Pasien HIV/AIDS di Puskesmas
Kecamatan Penjaringan Jakarta Utara Periode Tahun 2013 – 2015. Social
Clinical Pharmacy Indonesia Journal, 2: 29–37.
Benn, P., Sauret-Jackson, V., Cartledge, J., Ruff, C., Sabin, C., Moyle, G., dkk.,
2009. Improvements in Cheek Volume in Lipoatrophic Individuals
Switching Away from Thymidine Nucleoside Reverse Transcriptase
Inhibitors. HIV Medicine, 10: 351–355.
Berrada, S., Mkandawire, T., Kamungoma-Dada, I., Njuho, P., Thipa, N., Pinini,
Z., dkk., 2013. 'What are The Reasons for Switching ART Patients to
Second-Line Regimen in Public Healthcare Settings in Gauteng? Submitted
to the US Agency for International Development by the Systems for
Improved Access to Pharmaceuticals and Services (SIAPS) Program', .
Management Sciences for Health, Arlington, VA.
Perbandingan Luaran Terapi Rejimen Antiretroviral Lini Kedua pada Pasien HIV/AIDSWINDA DWI P., Dr. Nanang Munif Yasin, M.Pharm., Apt.; Dr. Fita Rahmawati Sp.FRS.,Apt.Universitas Gadjah Mada, 2018 | Diunduh dari http://etd.repository.ugm.ac.id/
110
Besral, B., Utomo, B., dan Zani, A.P., 2004. Potensi Penyebaran HIV dari
Pengguna NAPZA Suntik ke Masyarakat Umum. Makara Kesehatan, 8:
53–58.
Bezabhe, W.M., Bereznicki, L.R., Chalmers, L., Gee, P., Kassie, D.M., Bimirew,
M.A., dkk., 2015. Adverse Drug Reactions and Clinical Outcomes in
Patients Initiated on Antiretroviral Therapy: A Prospective Cohort Study
From Ethiopia. Drug Safety, 38: 629–639.
Biewenga, J., Keung, C., Solanki, B., Natarajan, J., Leitz, G., Deleu, S., dkk., 2015.
Absence of QTc Prolongation with Domperidone: A Randomized, Double-
Blind, Placebo- and Positive-Controlled Thorough QT/QTc Study in
Healthy Volunteers: Clinical Pharmacology in Drug Development. Clinical
Pharmacology in Drug Development, 4: 41–48.
BNN, 2004. Biaya Ekonomi dan Sosial Penyalahgunaan Narkoba di Indonesia,
dalam: Himpunan Hasil Penelitian Badan Narkotika Nasional 2003 Dan
2004. Badan Narkotika Nasional, Jakarta.
Boettiger, D.C., Nguyen, V.K., Durier, N., Bui, H.V., Heng Sim, B.L., Azwa, I.,
dkk., 2015. Efficacy of Second-Line Antiretroviral Therapy Among People
Living With HIV/AIDS in Asia: Results From the TREAT Asia HIV
Observational Database. JAIDS Journal of Acquired Immune Deficiency
Syndromes, 68: 186–195.
Bor, J., Herbst, A.J., Newell, M.-L., dan Bärnighausen, T., 2013. Increases in Adult
Life Expectancy in Rural South Africa: Valuing the Scale-up of HIV
Treatment. Science, 339: 961–965.
Boyd, M.A., Moore, C.L., Molina, J.-M., Wood, R., Madero, J.S., Wolff, M., dkk.,
2015. Baseline HIV-1 Resistance, Virological Outcomes, and Emergent
Resistance in the SECOND-LINE Trial: an Exploratory Analysis. The
Lancet HIV, 2: e42–e51.
Bunupuradah, T., Chetchotisakd, P., Ananworanich, J., Munsakul, W.,
Jirajariyavej, S., Kantipong, P., dkk., 2012. A Randomized Comparison of
Second-Line Lopinavir/Ritonavir Monotherapy vs.
Tenofovir/Lamivudine/Lopinavir/Ritonavir in Patients Failing NNRTI-
Regimens: The HIV STAR Study. Antiviral Therapy, 17: 1351–1361.
Bunyamin, J., 2014. 'Association between Stavudin Administration with
Lipodystrophy and Dyslipidemia among HIV-infected Patients in Dr.
Kariadi Hospital Semarang', , Skripsi, S. Ked., . Universitas Diponegoro,
Semarang.
Castro, K.G., Ward, J.W., Slutsker, L., Buehler, J.W., Jaffe, H.W., dan Berkelman,
R.L., 1992. '1993 Revised Classification System for HIV Infection and
Expanded Surveillance Case Definition for AIDS Among Adolescents and
Adults', . URL:
https://www.cdc.gov/mmwr/preview/mmwrhtml/00018871.htm (diakses
tanggal 28/3/2018).
Chakravarty, J., Sundar, S., Chourasia, A., Singh, P.N., Kurle, S., Tripathy, S.P.,
dkk., 2015. Outcome of Patients on Second Line Antiretroviral Therapy
Under Programmatic Condition in India. BMC infectious diseases, 15: 517.
Perbandingan Luaran Terapi Rejimen Antiretroviral Lini Kedua pada Pasien HIV/AIDSWINDA DWI P., Dr. Nanang Munif Yasin, M.Pharm., Apt.; Dr. Fita Rahmawati Sp.FRS.,Apt.Universitas Gadjah Mada, 2018 | Diunduh dari http://etd.repository.ugm.ac.id/
111
Charbonneau, D.H. dan James, L.N., 2018. DynaMed Plus®: An Evidence-Based
Clinical Reference Resource. Medical Reference Services Quarterly, 37:
168–176.
Chastain, D.B., Stover, K.R., dan Riche, D.M., 2017. Evidence-Based Review of
Statin Use in Patients with HIV on Antiretroviral Therapy. Journal of
Clinical & Translational Endocrinology, 8: 6–14.
Chauvin, B., Drouot, S., Barrail-Tran, A., dan Taburet, A.-M., 2013. Drug–Drug
Interactions between HMG-CoA Reductase Inhibitors (Statins) and
Antiviral Protease Inhibitors. Clinical Pharmacokinetics, 52: 815–831.
Chodidjah, S., Agustini, N., dan Ungsianik, T., 2004. Hubungan antara
Pengetahuan tentang HIV/AIDS dengan Perilaku Seksual Pranikah pada
Remaja. Jurnal Keperawatan Indonesia, 8: 50–53.
Ciaffi, L., Koulla-Shiro, S., Sawadogo, A., le Moing, V., Eymard-Duvernay, S.,
Izard, S., dkk., 2015. Efficacy and safety of three second-line antiretroviral
regimens in HIV-infected patients in Africa. AIDS (London, England), 29:
1473–1481.
Collier, D., Iwuji, C., Derache, A., de Oliveira, T., Okesola, N., Calmy, A., dkk.,
2017. Virological Outcomes of Second-line Protease Inhibitor-Based
Treatment for Human Immunodeficiency Virus Type 1 in a High-
Prevalence Rural South African Setting: A Competing-Risks Prospective
Cohort Analysis. Clinical Infectious Diseases: An Official Publication of
the Infectious Diseases Society of America, 64: 1006–1016.
Collins, I.J., Foster, C., Kahlert, C., Smit, C., Goodall, R., Marques, L., dkk., 2018.
Time to Switch to Second-line Antiretroviral Therapy in Children With
Human Immunodeficiency Virus in Europe and Thailand. Clinical
Infectious Diseases, 66: 594–603.
Curran, A. dan Ribera, E., 2011. From Old to New Nucleoside Reverse
Transcriptase Inhibitors: Changes in Body Fat Composition, Metabolic
Parameters and Mitochondrial Toxicity After the Switch from Thymidine
Analogs to Tenofovir or Abacavir. Expert Opinion on Drug Safety, 10: 389–
406.
Dahlan, M.S., 2014. Statistik Untuk Kedokteran Dan Kesehatan : Deskriptif,
Bivariat, Dan Multivariat Dilengkapi Aplikasi Menggunakan SPSS, Edisi
Keenam. ed. Epidemiologi Indonesia, Jakarta.
Damtie, D., Yismaw, G., Woldeyohannes, D., dan Anagaw, B., 2013. Common
Opportunistic Infections and Their CD4 Cell Correlates among HIV-
infected Patients Attending at Antiretroviral Therapy Clinic of Gondar
University Hospital, Northwest Ethiopia. BMC Research Notes, 6: 534.
Danion, F., Aguilar, C., Catherinot, E., Alanio, A., DeWolf, S., Lortholary, O., dkk.,
2015. Mucormycosis: New Developments into a Persistently Devastating
Infection. Seminars in Respiratory and Critical Care Medicine, 36: 692–
705.
De Luca, A., Sidumo, Z.J., Zanelli, G., Magid, N.A., Luhanga, R., Brambilla, D.,
dkk., 2017. Accumulation of HIV-1 Drug Resistance in Patients on a
Standard Thymidine Analogue-Based First Line Antiretroviral Therapy
After Virological Failure: Implications for the Activity of Next-Line
Perbandingan Luaran Terapi Rejimen Antiretroviral Lini Kedua pada Pasien HIV/AIDSWINDA DWI P., Dr. Nanang Munif Yasin, M.Pharm., Apt.; Dr. Fita Rahmawati Sp.FRS.,Apt.Universitas Gadjah Mada, 2018 | Diunduh dari http://etd.repository.ugm.ac.id/
112
Regimens from a Longitudinal Study in Mozambique. BMC Infectious
Diseases, 17: 605.
de Waal, R., Cohen, K., dan Maartens, G., 2013. Systematic Review of
Antiretroviral-Associated Lipodystrophy: Lipoatrophy, but Not Central Fat
Gain, Is an Antiretroviral Adverse Drug Reaction. PLoS ONE, 8: e63623.
Decloedt, E.H., Maartens, G., Smith, P., Merry, C., Bango, F., dan McIlleron, H.,
2012. The Safety, Effectiveness, and Concentrations of Adjusted
Lopinavir/Ritonavir in HIV-Infected Adults on Rifampicin-Based
Antitubercular Therapy. PLoS ONE, 7: e32173.
Delfraissy, J.-F., Flandre, P., Delaugerre, C., Ghosn, J., Horban, A., Girard, P.-M.,
dkk., 2008. Lopinavir/Ritonavir Monotherapy or Plus Zidovudine and
Lamivudine in Antiretroviral-Naive HIV-Infected Patients. AIDS, 22: 385–
393.
Depkes RI, 2004. Keputusan Menteri Kesehatan Republik Indonesia Tentang
Standar Pelayanan Farmasi Di Rumah Sakit. Departemen Kesehatan RI,
Jakarta.
Direktorat Bina Farmasi Komunitas dan Klinik, 2006. Pedoman Pelayanan
Kefarmasian Untuk Orang Dengan HIV/AIDS (ODHA). Direktorat Bina
Farmasi Komunitas dan Klinik, Ditjen Bina Kefarmasian dan Alat
Kesehatan, Departemen Kesehatan RI, Jakarta.
Ditjen PPM&PL, 2004. Pedoman Nasional Terapi Antiretroviral. Direktorat
Jenderal Pemberantasan Penyakit Menular dan Penyehatan Lingkungan,
Departemen Kesehatan RI, Jakarta.
Ditjen PP&PL, 2008. 'Statistik Kasus HIV/AIDS di Indonesia Dilaporkan Sampai
dengan Desember 2007', Yayasan Spiritia. URL:
http://www.spiritia.or.id/Stats/Statistik.php (diakses tanggal 4/2/2018).
Ditjen PP&PL, 2017. 'Statistik Kasus HIV/AIDS di Indonesia Dilaporkan Sampai
dengan Desember 2016', Yayasan Spiritia. URL:
http://www.spiritia.or.id/Stats/Statistik.php (diakses tanggal 4/2/2018).
Dooley, K.E., Flexner, C., dan Andrade, A.S., 2008. Drug Interactions Involving
Combination Antiretroviral Therapy and Other Anti‐Infective Agents:
Repercussions for Resource‐Limited Countries. The Journal of Infectious
Diseases, 198: 948–961.
Drugs.com, 2018. 'Drug Interaction Report', Drugs.com. URL:
https://www.drugs.com/interactions-check.php?drug_list=276-0,1096-
0,1484-0,1605-0,2012-0,2067-0,1863-15957&professional=1 (diakses
tanggal 12/3/2018).
Duval, X., Journot, V., Leport, C., Cheˆne, G., Dupon, M., Cuzin, L., dkk., 2004.
Incidence of and Risk Factors for Adverse Drug Reactions in a Prospective
Cohort of HIV-Infected Adults Initiating Protease Inhibitor–Containing
Therapy. Clinical Infectious Diseases, 39: 248–255.
Ehrenpreis, E.D., Roginsky, G., Alexoff, A., dan Smith, D.G., 2017. Domperidone
is Commonly Prescribed With QT-Interacting Drugs: Review of a
Community-based Practice and a Postmarketing Adverse Drug Event
Reporting Database. Journal of Clinical Gastroenterology, 51: 56–62.
Perbandingan Luaran Terapi Rejimen Antiretroviral Lini Kedua pada Pasien HIV/AIDSWINDA DWI P., Dr. Nanang Munif Yasin, M.Pharm., Apt.; Dr. Fita Rahmawati Sp.FRS.,Apt.Universitas Gadjah Mada, 2018 | Diunduh dari http://etd.repository.ugm.ac.id/
113
Eluwa, G.I., Badru, T., dan Akpoigbe, K.J., 2012. Adverse Drug Reactions to
Antiretroviral Therapy (ARVs): Incidence, Type and Risk Factors in
Nigeria. BMC Clinical Pharmacology, 12: 1–9.
Epstein, F.H., Pantaleo, G., Graziosi, C., dan Fauci, A.S., 1993. The
Immunopathogenesis of Human Immunodeficiency Virus Infection. New
England Journal of Medicine, 328: 327–335.
Evans, S.R., Ellis, R.J., Chen, H., Yeh, T., Lee, A.J., Schifitto, G., dkk., 2011.
Peripheral Neuropathy in HIV: Prevalence and Risk Factors. AIDS, 25:
919–928.
Fairall, L.R., Bachmann, M.O., Louwagie, G.M.C., Vuuren, C. van, Chikobvu, P.,
Steyn, D., dkk., 2008. Effectiveness of Antiretroviral Treatment in a South
African Program, A Cohort Study. Archives of Internal Medicine, 168: 86.
Ferradini, L., Ouk, V., Segeral, O., Nouhin, J., Dulioust, A., Hak, C., dkk., 2011.
High Efficacy of Lopinavir/r-based Second-Line Antiretroviral Treatment
After 24 Months of Follow Up at ESTHER/Calmette Hospital in Phnom
Penh, Cambodia. Journal of the International AIDS Society, 14: 14.
Finkelstein, J.L., Gala, P., Rochford, R., Glesby, M.J., dan Mehta, S., 2015.
HIV/AIDS and Lipodystrophy: Implications for Clinical Management in
Resource-limited Settings. Journal of the International AIDS Society, 18:
1–22.
Fletcher, C.V. dan Kakuda, T.N., 2005. Human Immunodeficiency Virus Infection.
Dipiro, J.T., Talbert, R.I., Yee, G.C., Maatzke, A., Wells, B.G., Passey,
L.M., dalam: Pharmacotherapy: A Pathophysiologic Approach. Appleton
and Lange, Philadelphia.
Ford, N., Shubber, Z., Hill, A., Vitoria, M., Doherty, M., Mills, E.J., dkk., 2013.
Comparative Efficacy of Lamivudine and Emtricitabine: A Systematic
Review and Meta-Analysis of Randomized Trials. PLoS ONE, 8: e79981.
Gilks, C.F., Walker, A.S., Munderi, P., Kityo, C., Reid, A., Katabira, E., dkk., 2013.
A Single CD4 Test with 250 Cells/mm3 Threshold Predicts Viral
Suppression in HIV-Infected Adults Failing First-Line Therapy by Clinical
Criteria. PLoS ONE, 8: e57580.
Gunda, D.W., Kidenya, B.R., Mshana, S.E., Kilonzo, S.B., dan Mpondo, B.C.T.,
2017. Accuracy of WHO Immunological Criteria in Identifying Virological
Failure among HIV-infected Adults on First Line Antiretroviral Therapy in
Mwanza, North-western Tanzania. BMC Research Notes, 10: 1–5.
Haggblom, A., Santacatterina, M., Neogi, U., Gisslen, M., Hejdeman, B., Flamholc,
L., dkk., 2017. Effect of Therapy Switch on Time to Second-Line
Antiretroviral Treatment Failure in HIV-Infected Patients. PLOS ONE, 12:
e0180140.
Hakim, J.G., Thompson, J., Kityo, C., Hoppe, A., Kambugu, A., van Oosterhout,
J.J., dkk., 2017. Lopinavir Plus Nucleoside Reverse-Transcriptase
Inhibitors, Lopinavir Plus Raltegravir, or Lopinavir Monotherapy for
Second-Line Treatment of HIV (EARNEST): 144-Week Follow-up Results
from a Randomised Controlled Trial. The Lancet Infectious Diseases, 18:
47–57.
Perbandingan Luaran Terapi Rejimen Antiretroviral Lini Kedua pada Pasien HIV/AIDSWINDA DWI P., Dr. Nanang Munif Yasin, M.Pharm., Apt.; Dr. Fita Rahmawati Sp.FRS.,Apt.Universitas Gadjah Mada, 2018 | Diunduh dari http://etd.repository.ugm.ac.id/
114
Han, Y., Li, Yijia, Xie, J., Qiu, Z., Li, Yanling, Song, X., dkk., 2015. Week 120
Efficacy of Tenofovir, Lamivudine, and Lopinavir/r-Based Second-Line
Antiretroviral Therapy in Treatment-Experienced HIV Patients. PLOS
ONE, 10: e0120705.
Hawkins, T., 2010. Understanding and Managing the Adverse Effects of
Antiretroviral Therapy. Antiviral Research, 85: 201–209.
Hidayati, N.R., Abdillah, S., dan Keban, S.A., 2016. Analisis Adverse Drug
Reactions Obat Antiretroviral pada Pengobatan Pasien HIV/AIDS di RSUD
Gunung Jati Cirebon Tahun 2013. Pharmaciana, 6: 79–88.
Hughes, C.A., Foisy, M., dan Tseng, A., 2010. Interactions Between Antifungal and
Antiretroviral Agents. Expert Opinion on Drug Safety, 9: 723–742.
Jamil, K.F., 2014. Profil Kadar CD4 terhadap Infeksi Oportunistik pada Penderita
Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome
(HIV/AIDS) Di RSUD Dr. Zainoel Abidin Banda Aceh. Jurnal Kedokteran
Syiah Kuala, 14: 76–80.
Jensen-Fangel, S., 2004. The Effectiveness of Highly Active Antiretroviral Therapy
in HIV-Infected Patients. Dan Med Bull, 51: 371–92.
Johnston, V., Cohen, K., Wiesner, L., Morris, L., Ledwaba, J., Fielding, K.L., dkk.,
2014. Viral Suppression Following Switch to Second-line Antiretroviral
Therapy: Associations With Nucleoside Reverse Transcriptase Inhibitor
Resistance and Subtherapeutic Drug Concentrations Prior to Switch. The
Journal of Infectious Diseases, 209: 711–720.
Johnston, V., Fielding, K., Charalambous, S., Mampho, M., Churchyard, G.,
Phillips, A., dkk., 2012. Second-Line Antiretroviral Therapy in a Workplace
and Community-Based Treatment Programme in South Africa:
Determinants of Virological Outcome. PLoS ONE, 7: e36997.
Kemenkes RI, 2007. 'Keputusan Menteri Kesehatan Republik Indonesia tentang
Penetapan Lanjutan Rumah Sakit Rujukan bagi Orang Dengan HIV dan
AIDS (ODHA)', Komisi Penanggulangan AIDS. URL:
http://www.aidsindonesia.or.id/uploads/20130506131726.Skmenkes_Nom
or_760_MENKES_SK_VI_2007_Tentang_Penetapan_Lanjutan_Rumah_
Sakit_Rujukan_Bagi_Orang_Dengan_HIV_dan_AIDS_ODHA.pdf
(diakses tanggal 6/2/2018).
Kemenkes RI, 2012. Pedoman Nasional Tatalaksana Klinis Infeksi HIV dan Terapi
Antiretroviral pada Orang Dewasa dan Remaja. Direktorat Jenderal
Pengendalian Penyakit dan Penyehatan Lingkungan, Kementerian
Kesehatan RI, Jakarta.
Kemenkes RI, 2015. Peraturan Menteri Kesehatan Republik Indonesia Nomor 87
Tahun 2014 tentang Pedoman Pengobatan Antiretroviral. Kementerian
Kesehatan Republik Indonesia, Jakarta.
Kouotou, E.A., Nansseu, J.R., Ngono, V.N., Tatah, S.A., Zoung-Kanyi Bissek,
A.C., dan Ndjitoyap Ndam, E.C., 2017. Prevalence and Clinical Profile of
Drug Eruptions among Antiretroviral Therapy-Exposed HIV Infected
People in Yaoundé, Cameroon. Dermatology Research and Practice, 2017:
1–6.
Perbandingan Luaran Terapi Rejimen Antiretroviral Lini Kedua pada Pasien HIV/AIDSWINDA DWI P., Dr. Nanang Munif Yasin, M.Pharm., Apt.; Dr. Fita Rahmawati Sp.FRS.,Apt.Universitas Gadjah Mada, 2018 | Diunduh dari http://etd.repository.ugm.ac.id/
115
KPAN, 2007. 'Strategi Nasional Penanggulangan HIV dan AIDS 2007-2010',
Yayasan Spiritia. URL: http://spiritia.or.id/dokumen/stranas07-10.pdf
(diakses tanggal 6/2/2018).
KPAN, 2011. 'Rangkuman Eksekutif Upaya Penanggulangan HIV dan AIDS di
Indonesia 2006 - 2011: Laporan 5 Tahun Pelaksanaan Peraturan Presiden
No. 75/2006 tentang Komisi Penanggulangan AIDS Nasional', Komisi
Penanggulangan AIDS. URL:
http://www.aidsindonesia.or.id/repo/ExSumLap5thnInd.pdf (diakses
tanggal 4/4/2018).
KPAN, 2015. 'Strategi dan Rencana Aksi Nasional 2015-2019 Penanggulangan
HIV dan AIDS di Indonesia', Sistem Informasi HIV/AIDS&IMS Online
Kemenkes RI. URL:
siha.depkes.go.id/portal/files_upload/SRAN_2015_2019_FINAL.pdf
(diakses tanggal 4/4/2018).
Li, H., Marley, G., Ma, W., Wei, C., Lackey, M., Ma, Q., dkk., 2016. The Role of
ARV Associated Adverse Drug Reactions in Influencing Adherence Among
HIV-Infected Individuals: A Systematic Review and Qualitative Meta-
Synthesis. AIDS and Behavior, 21: 341–351.
Li, M. dan Ramos, L.G., 2017. Drug-Induced QT Prolongation And Torsades de
Pointes. Pharmacovigilance Forum, 42: 473–477.
Lim, M.L., Min, S.S., Eron, J.J., Bertz, R.J., Robinson, M., Gaedigk, A., dkk., 2004.
Coadministration of Lopinavir/Ritonavir and Phenytoin Results in Two-
Way Drug Interaction Through Cytochrome P-450 Induction. Journal of
Acquired Immune Deficiency Syndromes (1999), 36: 1034–1040.
Low, A., Gavriilidis, G., Larke, N., B-Lajoie, M.-R., Drouin, O., Stover, J., dkk.,
2016. Incidence of Opportunistic Infections and the Impact of Antiretroviral
Therapy Among HIV-Infected Adults in Low- and Middle-Income
Countries: A Systematic Review and Meta-analysis. Clinical Infectious
Diseases, 62: 1595–1603.
Luma, H.N., Doualla, M.-S., Choukem, S.-P., Temfack, E., Ashuntantang, G., Joko,
H.A., dkk., 2012. Adverse Drug Reactions of Highly Active Antiretroviral
Therapy (HAART) in HIV Infected Patients at the General Hospital,
Douala, Cameroon: A Cross Sectional Study. Pan African Medical Journal,
12: 1–7.
Manosuthi, W., Wiboonchutikul, S., dan Sungkanuparph, S., 2016. Integrated
Therapy for HIV and Tuberculosis. AIDS Research and Therapy, 13: 1–12.
Masenyetse, L.J., Manda, S., dan Mwambi, H.G., 2015. An Assessment of Adverse
Drug Reactions Among HIV Positive Patients Receiving Antiretroviral
Treatment in South Africa. AIDS Research and Therapy, 12: 6.
Mathis, S., Khanlari, B., Pulido, F., Schechter, M., Negredo, E., Nelson, M., dkk.,
2011. Effectiveness of Protease Inhibitor Monotherapy versus Combination
Antiretroviral Maintenance Therapy: A Meta-Analysis. PLoS ONE, 6:
e22003.
May, M.T., Vehreschild, J.-J., Trickey, A., Obel, N., Reiss, P., Bonnet, F., dkk.,
2016. Mortality According to CD4 Count at Start of Combination
Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15
Perbandingan Luaran Terapi Rejimen Antiretroviral Lini Kedua pada Pasien HIV/AIDSWINDA DWI P., Dr. Nanang Munif Yasin, M.Pharm., Apt.; Dr. Fita Rahmawati Sp.FRS.,Apt.Universitas Gadjah Mada, 2018 | Diunduh dari http://etd.repository.ugm.ac.id/
116
Years After Start of Treatment: Collaborative Cohort Study. Clinical
Infectious Diseases, 62: 1571–1577.
Mayer, K.H. dan Hamilton, C.D., 2010. Synergistic Pandemics: Confronting the
Global HIV and Tuberculosis Epidemics. Clinical Infectious Diseases, 50:
S67–S70.
Mehta, U. dan Maartens, G., 2007. Is It Safe to Switch between Efavirenz and
Nevirapine in The Event of Toxicity? The Lancet Infectious Disease, 7:
733–738.
Moyle, G.J., Sabin, C.A., Cartledge, J., Johnson, M., Wilkins, E., Churchill, D.,
dkk., 2006. A Randomized Comparative Trial of Tenofovir DF or Abacavir
as Replacement for a Thymidine Analogue in Persons with Lipoatrophy.
AIDS, 20: 2043–2050.
Muhič, N., Mrhar, A., dan Brvar, M., 2017. Comparative Analysis of Three Drug–
Drug Interaction Screening Systems Against Probable Clinically Relevant
Drug–Drug Interactions: A Prospective Cohort Study. European Journal of
Clinical Pharmacology, 73: 875–882.
Nila, A., 2012. 'Evaluasi Kejadian Efek Samping Neuropati Perifer dan Lipodistrofi
pada Pasien HIV/AIDS yang Menggunakan Stavudin dalam Rejimen
Antiretroviral di Rumah Sakit Kanker Dharmais Jakarta', , Tesis, M. Farm.,
. Universitas Indonesia, Depok.
Nursalam dan Kurniawati, N.D., 2007. Asuhan Keperawatan Pada Pasien
Terinfeksi HIV/AIDS. Salemba Medika, Jakarta.
Nwabueze, S.A., Joe-Ikechebelu, N.N., Modebe, I.A., Adogu, P.O.U., dan Ele,
P.U., 2013. Relationship Between Peripheral Neuropathy and Antiretroviral
Drugs Used in the Management of Adult Human Immunodeficiency Virus
Patients. Journal of HIV & Human Reproduction, 1: 36–40.
Onyedum, C.C., Iroezindu, M.O., Chukwuka, C.J., Anyaene, C.E., Obi, F.I., dan
Young, E.E., 2013. Profile of HIV-infected Patients Receiving Second-line
Antiretroviral Therapy in a Resource-limited Setting in Nigeria.
Transactions of the Royal Society of Tropical Medicine and Hygiene, 107:
608–614.
Osinusi-Adekanmbi, O., Stafford, K., Ukpaka, A., Salami, D., Ajayi, S., Ndembi,
N., dkk., 2014a. Long-Term Outcome of Second-Line Antiretroviral
Therapy in Resource-Limited Settings. Journal of the International
Association of Providers of AIDS Care (JIAPAC), 13: 366–371.
Oumar, A.A., Diallo, K., Dembélé, J.P., Samaké, L., Sidibé, I., Togo, B., dkk.,
2012. Adverse Drug Reactions to Antiretroviral Therapy: Prospective Study
in Children in Sikasso (Mali). The Journal of Pediatric Pharmacology and
Therapeutics, 17: 382–388.
Palombi, L., Marazzi, M.C., Guidotti, G., Germano, P., Buonomo, E., Scarcella, P.,
dkk., 2009. Incidence and Predictors of Death, Retention, and Switch to
Second‐Line Regimens in Antiretroviral‐Treated Patients in Sub‐Saharan
African Sites with Comprehensive Monitoring Availability. Clinical
Infectious Diseases, 48: 115–122.
Perbandingan Luaran Terapi Rejimen Antiretroviral Lini Kedua pada Pasien HIV/AIDSWINDA DWI P., Dr. Nanang Munif Yasin, M.Pharm., Apt.; Dr. Fita Rahmawati Sp.FRS.,Apt.Universitas Gadjah Mada, 2018 | Diunduh dari http://etd.repository.ugm.ac.id/
117
Panel on Antiretroviral Guidelines for Adults and Adolescents, 2017. Guidelines
for the Use of Antiretroviral Agents in Adults and Adolescents Living with
HIV. Department of Health and Human Services.
Patel, D., Desai, M., Shah, A.N., dan Dikshit, R.K., 2013. Early Outcome of Second
Line Antiretroviral Therapy in Treatment-Experienced Human
Immunodeficiency Virus Positive Patients. Perspectives in Clinical
Research, 4: 215–220.
Paton, N.I., Kityo, C., Hoppe, A., Reid, A., Kambugu, A., Lugemwa, A., dkk.,
2014. Assessment of Second-Line Antiretroviral Regimens for HIV
Therapy in Africa. New England Journal of Medicine, 371: 234–247.
Perwira, I., 2015. 'Profilaksis Pra Pajanan (PPrP) sebagai Alternatif Pencegahan
Penularan HIV', Kebijakan AIDS Indonesia. URL:
http://www.kebijakanaidsindonesia.net/id/artikel/artikel-tematik/1378-
profilaksis-pra-pajanan-pprp-sebagai-alternatif-pencegahan-penularan-hiv
(diakses tanggal 6/2/2018).
Pettersen, J.A., Jones, G., Worthington, C., Krentz, H.B., Keppler, O.T., Hoke, A.,
dkk., 2006. Sensory Neuropathy in Human Immunodeficiency
Virus/Acquired Immunodeficiency Syndrome Patients: Protease Inhibitor–
Mediated Neurotoxicity. Annals of Neurology, 59: 816–824.
Pirmohamed, M., Atuah, K.N., Dodoo, A.N.O., dan Winstanley, P., 2007.
Pharmacovigilance in Developing Countries. BMJ, 335: 462–462.
Pokala, N., Dixit, R., Manubhai, P.M., dan Vijayal, K., 2014. Adverse Drug
Reactions with Second Line Antiretroviral Drug Regimen. Asian Journal of
Pharmaceutical and Clinical Research, 7: 75–79.
Prasitsuebsai, W., Teeraananchai, S., Singtoroj, T., Truong, K.H., Ananworanich,
J., Do, V.C., dkk., 2016. Treatment Outcomes and Resistance Patterns of
Children and Adolescents on Second-Line Antiretroviral Therapy in Asia.
Journal of Acquired Immune Deficiency Syndromes (1999), 72: 380–386.
Preston, C.L., Elaina E Crehan, Driver, S., Hatwal, C.S., Jones, S.L., Khan, S.Z.,
dkk., 2014. Stockley’s Drug Interactions Pocket Companion 2015.
Pharmaceutical Press, London.
Pujades-Rodríguez, M., Balkan, S., Arnould, L., Brinkhof, M.A.W., dan Calmy, A.,
2010. Treatment Failure and Mortality Factors in Patients Receiving
Second-Line HIV Therapy in Resource-Limited Countries. JAMA, 304:
303.
Pusdatin Kemenkes RI, 2016. Situasi Penyakit HIV/AIDS Di Indonesia.
InfoDATIN, Pusat Data dan Informasi Kementerian Kesehatan RI, Jakarta.
Raffi, F., Babiker, A.G., Richert, L., Molina, J.-M., George, E.C., Antinori, A.,
dkk., 2014. Ritonavir-Boosted Darunavir Combined with Raltegravir or
Tenofovir–Emtricitabine in Antiretroviral-Naive Adults Infected with HIV-
1: 96 Week Results from the NEAT001/ANRS143 Randomised Non-
Inferiority Trial. The Lancet, 384: 1942–1951.
Ramadhani, H.O., Bartlett, J.A., Thielman, N.M., Pence, B.W., Kimani, S.M.,
Maro, V.P., dkk., 2014. Association of First-Line and Second-Line
Antiretroviral Therapy Adherence. Open Forum Infectious Diseases, 1:
ofu079–ofu079.
Perbandingan Luaran Terapi Rejimen Antiretroviral Lini Kedua pada Pasien HIV/AIDSWINDA DWI P., Dr. Nanang Munif Yasin, M.Pharm., Apt.; Dr. Fita Rahmawati Sp.FRS.,Apt.Universitas Gadjah Mada, 2018 | Diunduh dari http://etd.repository.ugm.ac.id/
118
Ramadhani, H.O., Bartlett, J.A., Thielman, N.M., Pence, B.W., Kimani, S.M.,
Maro, V.P., dkk., 2016. The Effect of Switching to Second-Line
Antiretroviral Therapy on the Risk of Opportunistic Infections among
Patients Infected with Human Immunodeficiency Virus in Northern
Tanzania. Open Forum Infectious Diseases, 3: ofw018.
Reynes, J., Lawal, A., Pulido, F., Soto-Malave, R., Gathe, J., Tian, M., dkk., 2011.
Examination of Noninferiority, Safety, and Tolerability of
Lopinavir/ritonavir and Raltegravir Compared with Lopinavir/ritonavir and
Tenofovir/ Emtricitabine in Antiretroviral-Naïve Subjects: The
PROGRESS Study, 48-Week Results. HIV Clinical Trials, 12: 255–267.
Reynes, J., Trinh, R., Pulido, F., Soto-Malave, R., Gathe, J., Qaqish, R., dkk., 2012.
Lopinavir/Ritonavir Combined with Raltegravir or Tenofovir/Emtricitabine
in Antiretroviral-Naive Subjects: 96-Week Results of the PROGRESS
Study. AIDS Research and Human Retroviruses, 120803082830003.
Sattler, F.R., 2008. Pathogenesis and Treatment of Lipodystrophy : What Clinicians
Need to Know. Topics in HIV Medicine, 16: 127–133.
Sears, D.W., 2009. 'Structure of HIV', Biosci Portal. URL:
https://biosci.mcdb.ucsb.edu/immunology/Immunodeficiencies/HIV-
structure.htm (diakses tanggal 21/3/2017).
Shet, A., Antony, J., Arumugam, K., Kumar Dodderi, S., Rodrigues, R., dan
DeCosta, A., 2014. Influence of Adverse Drug Reactions on Treatment
Success: Prospective Cohort Analysis of HIV-Infected Individuals
Initiating First-Line Antiretroviral Therapy in India. PLoS ONE, 9: e91028.
Soorju, V. dan Naidoo, P., 2016. Confirmation of Factors That Influence
Antiretroviral Regimen Change and the Subsequent Patient Outcomes at a
Regional Hospital in Rural Kwazulu-Natal. African Journal of Primary
Health Care & Family Medicine, 8: 1–6.
Ssempijja, V., Nakigozi, G., Chang, L., Gray, R., Wawer, M., Ndyanabo, A., dkk.,
2017. Rates of Switching to Second-Line Antiretroviral Therapy and Impact
of Delayed Switching on Immunologic, Virologic, and Mortality Outcomes
Among HIV-Infected Adults with Virologic Failure in Rakai, Uganda. BMC
Infectious Diseases, 17: 1–10.
Stockdale, A.J., Saunders, M.J., Boyd, M.A., Bonnett, L.J., Johnston, V., Wandeler,
G., dkk., 2017. Effectiveness of Protease Inhibitor/Nucleos(t)ide Reverse
Transcriptase Inhibitor–Based Second-line Antiretroviral Therapy for the
Treatment of Human Immunodeficiency Virus Type 1 Infection in Sub-
Saharan Africa: A Systematic Review and Meta-analysis. Clinical
Infectious Diseases, XX: 1–12.
Sugiharti, S., Yuniar, Y., dan Lestary, H., 2014. Gambaran Kepatuhan Orang
dengan HIV/AIDS (ODHA) dalam Minum Obat ARV di Kota Bandung,
Provinsi Jawa Barat, Tahun 2011-2012. Jurnal Kesehatan Reproduksi, 5:
11.
Sunpath, H., Winternheimer, P., Cohen, S., Tennant, I., Chelin, N., Gandhi, R.T.,
dkk., 2014. Double-Dose Lopinavir-Ritonavir in Combination with
Rifampicin-Based Anti-Tuberculosis Treatment in South Africa. The
International Journal of Tuberculosis and Lung Disease: The Official
Perbandingan Luaran Terapi Rejimen Antiretroviral Lini Kedua pada Pasien HIV/AIDSWINDA DWI P., Dr. Nanang Munif Yasin, M.Pharm., Apt.; Dr. Fita Rahmawati Sp.FRS.,Apt.Universitas Gadjah Mada, 2018 | Diunduh dari http://etd.repository.ugm.ac.id/
119
Journal of the International Union Against Tuberculosis and Lung Disease,
18: 689–693.
Tambunan, R., Kamil, O., Praptoraharjo, I., Erlan, H., dan Irwanto, 2010. 'Jaringan
Seksual dan Penggunaan NAPZA pada Pengguna NAPZA Suntik di 6
Propinsi', Komisi Penanggulangan AIDS. URL:
www.aidsindonesia.or.id/repo/perpustakaan/jaringanseksidu.pdf (diakses
tanggal 4/4/2018).
Thao, V.P., Quang, V.M., Wolbers, M., Anh, N.D., Shikuma, C., Farrar, J., dkk.,
2015. Second-Line HIV Therapy Outcomes and Determinants of Mortality
at the Largest HIV Referral Center in Southern Vietnam. Medicine, 94:
e1715.
Tisdale, J.E., 2016. Drug-Induced Qt Interval Prolongation and Torsades De
Pointes. Canadian Pharmacists Journal : CPJ, 149: 139–152.
Truven Health Analytics, 2011. 'Lopinavir/ritonavir', DynaMed Plus. URL:
http://www.dynamed.com/topics/dmp~AN~T232794/Lopinavir-
Ritonavir#Drug-Interactions (diakses tanggal 12/3/2018).
Tsegaye, A.T., Wubshet, M., Awoke, T., dan Addis Alene, K., 2016. Predictors of
Treatment Failure on Second-Line Antiretroviral Therapy Among Adults in
Northwest Ethiopia: A Multicentre Retrospective Follow-up Study. BMJ
Open, 6: e012537.
UNAIDS, 2016a. 'Global AIDS Update 2016', UNAIDS. URL:
http://www.unaids.org/sites/default/files/media_asset/global-AIDS-update-
2016_en.pdf (diakses tanggal 28/3/2018).
UNAIDS, 2016b. 'AIDS by the Numbers, AIDS is Not Over, but It Can Be', . URL:
http://www.unaids.org/sites/default/files/media_asset/AIDS-by-the-
numbers-2016_en.pdf (diakses tanggal 28/3/2018).
UNAIDS, 2016c. 'Country Factsheets Indonesia 2016', AIDSinfo. URL:
http://aidsinfo.unaids.org/ (diakses tanggal 28/3/2018).
Vadlapatla, R.K., Patel, M., Paturi, D.K., Pal, D., dan Mitra, A.K., 2014. Clinically
Relevant Drug–Drug Interactions Between Antiretrovirals and Antifungals.
Expert Opinion on Drug Metabolism & Toxicology, 10: 561–580.
Wandeler, G., Rohr, J., Chi, B.H., Orrell, C., Chimbetete, C., Prozesky, H., dkk.,
2014. Tenofovir or Zidovudine in Second-Line Antiretroviral Therapy After
Stavudine Failure in Southern Africa. Antiviral Therapy, 19: 521–525.
WHO, 2013a. Consolidated Guidelines on the Use of Antiretroviral Drugs for
Treating and Preventing HIV Infection: Recommendations for a Public
Health Approach. World Health Organization, Geneva, Switzerland.
WHO, 2013b. 'Summary of Key ARV Drug Interactions', World Health
Organization. URL:
http://apps.who.int/iris/bitstream/10665/91047/1/WHO_HIV_2013.66_eng
.pdf?ua=1 (diakses tanggal 3/12/2018).
WHO, 2013c. 'How Accurately Do the WHO 2010 Immunological or Clinical
Criteria Predict Virological Failure in Adults and Children Receiving
ART?', World Health Organization. URL:
http://apps.who.int/iris/bitstream/handle/10665/91031/WHO_HIV_2013.4
3_eng.pdf?sequence=1 (diakses tanggal 4/4/2018).
Perbandingan Luaran Terapi Rejimen Antiretroviral Lini Kedua pada Pasien HIV/AIDSWINDA DWI P., Dr. Nanang Munif Yasin, M.Pharm., Apt.; Dr. Fita Rahmawati Sp.FRS.,Apt.Universitas Gadjah Mada, 2018 | Diunduh dari http://etd.repository.ugm.ac.id/
120
Winarno, H., Suryoputro, A., dan Shaluhiyah, Z., 2008. Faktor-Faktor yang
Berhubungan dengan Penggunaan Jarum Suntik Bergantian di antara
Pengguna NAPZA Suntik di Kota Semarang. Jurnal Promosi Kesehatan
Indonesia, 3: 74–85.
Yasin, N.M., Maranty, H., dan Ningsih, W.R., 2011. Analisis Respon Terapi
Antiretroviral pada Pasien HIV/AIDS. Majalah Farmasi Indonesia, 22:
212–222.
Perbandingan Luaran Terapi Rejimen Antiretroviral Lini Kedua pada Pasien HIV/AIDSWINDA DWI P., Dr. Nanang Munif Yasin, M.Pharm., Apt.; Dr. Fita Rahmawati Sp.FRS.,Apt.Universitas Gadjah Mada, 2018 | Diunduh dari http://etd.repository.ugm.ac.id/